Juknevičienė, M.; Balnytė, I.; Valančiūtė, A.; Alonso, M.M.; Preikšaitis, A.; Sužiedėlis, K.; Stakišaitis, D.
Differential Impact of Valproic Acid on SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 Expression in Adult Glioblastoma Cells. Biomedicines 2024, 12, 1416.
https://doi.org/10.3390/biomedicines12071416
AMA Style
Juknevičienė M, Balnytė I, Valančiūtė A, Alonso MM, Preikšaitis A, Sužiedėlis K, Stakišaitis D.
Differential Impact of Valproic Acid on SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 Expression in Adult Glioblastoma Cells. Biomedicines. 2024; 12(7):1416.
https://doi.org/10.3390/biomedicines12071416
Chicago/Turabian Style
Juknevičienė, Milda, Ingrida Balnytė, Angelija Valančiūtė, Marta Marija Alonso, Aidanas Preikšaitis, Kęstutis Sužiedėlis, and Donatas Stakišaitis.
2024. "Differential Impact of Valproic Acid on SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 Expression in Adult Glioblastoma Cells" Biomedicines 12, no. 7: 1416.
https://doi.org/10.3390/biomedicines12071416
APA Style
Juknevičienė, M., Balnytė, I., Valančiūtė, A., Alonso, M. M., Preikšaitis, A., Sužiedėlis, K., & Stakišaitis, D.
(2024). Differential Impact of Valproic Acid on SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 Expression in Adult Glioblastoma Cells. Biomedicines, 12(7), 1416.
https://doi.org/10.3390/biomedicines12071416